Page last updated: 2024-10-30

mechlorethamine and Neoplasms, Otorhinolaryngologic

mechlorethamine has been researched along with Neoplasms, Otorhinolaryngologic in 1 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Research Excerpts

ExcerptRelevanceReference
"Neoadjuvant chemotherapy in Hodgkin's disease has improved survival time and tolerance to irradiation, allowing a lowering of the total doses used and the volumes irradiated."1.28[Radiotherapy with neoadjuvant chemotherapy]. ( Alapetite, C; Baillet, F; Dessard-Diana, B; Housset, M; Jacquillat, C; Michel-Langlet, P, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baillet, F1
Housset, M1
Dessard-Diana, B1
Jacquillat, C1
Michel-Langlet, P1
Alapetite, C1

Other Studies

1 other study available for mechlorethamine and Neoplasms, Otorhinolaryngologic

ArticleYear
[Radiotherapy with neoadjuvant chemotherapy].
    Annales de medecine interne, 1989, Volume: 140, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorub

1989